Related references
Note: Only part of the references are listed.Effects of oral testosterone treatment on myocardial perfusion and vascular function in men with low plasma testosterone and coronary heart disease
Carolyn M. Webb et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Effects of Testosterone on Antioxidant Systems in Male Secondary Hypogonadism
Antonio Mancini et al.
JOURNAL OF ANDROLOGY (2008)
Low serum testosterone and mortality in older men
Gail A. Laughlin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) prospective population study
Kay-Tee Khaw et al.
CIRCULATION (2007)
Relation between duration of androgen deprivation therapy and degree of insulin resistance in men with prostate cancer
Shehzad Basaria et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Low testosterone levels are associated with coronary artery disease in male patients with angina
G. M. C. Rosano et al.
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2007)
Androgens and diabetes in men - Results from the Third National Health and Nutrition Examination Survey (NHANES III)
Elizabeth Selvin et al.
DIABETES CARE (2007)
Reduced number of circulating endothelial progenitor cells in hypogonadal men
C. Foresta et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
Nancy L. Keating et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy
Milena Braga-Basaria et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Low serum testosterone and mortality in male veterans
Molly M. Shores et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy
S Basaria et al.
CANCER (2006)
Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men
M Maggio et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men
DE Laaksonen et al.
DIABETES CARE (2004)
The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men
CJ Malkin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Endogenous sex hormones and progression of carotid atherosclerosis in elderly men
M Muller et al.
CIRCULATION (2004)
The vasodilatory action of testosterone: a potassium-channel opening or a calcium antagonistic action?
RD Jones et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Low levels of endogtenous androgens increase the risk of atherosclerosis in elderly men: The Rotterdam study
AE Hak et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer
JC Smith et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Hypogonadism and androgen replacement therapy in elderly men
S Basaria et al.
AMERICAN JOURNAL OF MEDICINE (2001)
Effect of testosterone on plaque development and androgen receptor expression in the arterial vessel wall
H Hanke et al.
CIRCULATION (2001)
Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina - A randomized, double-blind, placebo-controlled study
KM English et al.
CIRCULATION (2000)
Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men - Prospective results from the Massachusetts Male Aging Study
RK Stellato et al.
DIABETES CARE (2000)
Share Paper
